BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership3,802,930 shares
Latest Disclosed Value $ 214,803,851
Dimensional Fund Advisors Lp reports 14.49% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 3,802,930 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $214,827,516 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 3,321,754 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 14.49% during the quarter. The current value of the position is $207,868,154 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,802,930 481,176 14.49 214,804 8.81 0.0096
2026-02-12 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,321,754 1,076,568 47.95 197,405 62.34 0.0414
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,245,186 671,566 42.68 121,597 40.56 0.0261
2025-08-12 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,573,620 406,125 34.79 86,507 4.81 0.0200
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,167,495 14,582 1.26 82,536 8.92 0.0205
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,152,913 -186,808 -13.94 75,779 -19.53 0.0182
2024-11-07 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,339,721 305,264 29.51 94,174 10.56 0.0228
2024-08-09 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,034,457 289,953 38.95 85,178 30.99 0.0222
2024-05-10 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 744,504 39,551 5.61 65,025 -4.34 0.0176
2024-02-07 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 704,953 71,853 11.35 67,975 21.34 0.0198
2023-11-09 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 633,100 -14,603 -2.25 56,021 -0.24 0.0184
2023-08-09 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 647,703 33,581 5.47 56,153 -5.96 0.0179
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 614,122 35,630 6.16 59,709 101,101.69 0.0201
2023-02-09 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 578,492 10,558 1.86 60 -99.88 0.0177
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 567,934 7,370 1.31 48,146 3.64 0.0185
2022-08-12 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 560,564 6,434 1.16 46,456 8.72 0.0167
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 554,130 2,108 0.38 42,729 -12.40 0.0132
2022-02-09 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 552,022 26,813 5.11 48,775 20.16 0.0147
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 525,209 51,547 10.88 40,592 2.71 0.0131
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 473,662 28,376 6.37 39,522 17.55 0.0125
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 445,286 16,990 3.97 33,622 -10.47 0.0111
2021-03-08 2020-12-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 428,296 3,919 0.92 37,555 16.32 0.0136
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 428,296 3,919 37,555 13,562.8698
2020-11-12 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 424,377 34,932 8.97 32,286 -32.78 0.0137
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 389,445 15,040 4.02 48,032 51.85 0.0211
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 374,405 179 0.05 31,632 -0.03 0.0165
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 374,226 21,728 6.16 31,641 33.17 0.0115
2019-11-12 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 352,498 13,474 3.97 23,760 -18.16 0.0092
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 339,024 8,925 2.70 29,034 -0.98 0.0113
2019-08-12 2019-03-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 330,099 20,320 6.56 29,321 11.17 0.0117
2019-05-10 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 330,099 20,320 29,321
2019-02-26 2018-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 309,779 21,009 7.28 26,375 -5.82 0.0119
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 309,779 21,009 26,375
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 288,770 66,986 30.20 28,004 34.09 0.0107
2018-08-10 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 221,784 -1,152 -0.52 20,885 15.56 0.0083
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 222,936 21,299 10.56 18,073 0.50 0.0075
2018-02-12 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 201,637 4,975 2.53 17,983 -1.75 0.0075
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 196,662 6,093 3.20 18,303 5.75 0.0080
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 190,569 2,422 1.29 17,307 4.78 0.0080
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 188,147 7,501 4.15 16,517 10.36 0.0079
2017-02-09 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 180,646 7,130 4.11 14,966 -6.78 0.0075
2016-11-10 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 173,516 12,317 7.64 16,054 27.99 0.0087
2016-08-09 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 161,199 3,332 2.11 12,543 -3.61 0.0072
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 157,867 3,941 2.56 13,013 -19.31 0.0078
2016-02-10 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 153,926 7,529 5.14 16,127 4.68 0.0101
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 146,397 -852 -0.58 15,406 -23.49 0.0101
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 147,249 14,221 10.69 20,135 21.40 0.0123
2015-05-14 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 133,028 2,989 2.30 16,585 41.08 0.0105
2015-02-06 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 130,039 2,851 2.24 11,756 28.06 0.0077
2014-11-13 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 127,188 -40,033 -23.94 9,180 -11.76 0.0065
2014-08-08 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 167,221 -2,789 -1.64 10,404 -10.30 0.0072
2014-05-14 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 170,010 -500 -0.29 11,599 -3.17 0.0087
2014-02-12 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 170,510 164 0.10 11,979 -2.66 0.0093
2013-11-13 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 170,346 1,296 0.77 12,306 30.44 0.0107
2013-08-15 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 169,050 169,050 9,434 0.0089
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.